Home/Filings/4/0001181431-11-020584
4//SEC Filing

Lonczak David Lawrence 4

Accession 0001181431-11-020584

CIK 0001086467other

Filed

Mar 28, 8:00 PM ET

Accepted

Mar 29, 5:32 PM ET

Size

14.4 KB

Accession

0001181431-11-020584

Insider Transaction Report

Form 4
Period: 2011-03-25
Lonczak David Lawrence
VP, Chief Marketing Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2011-03-25$2.54/sh+77,142$195,941221,620 total
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2011-03-25$3.90/sh50,000$195,000125,000 total
    Exercise: $2.68From: 2008-02-15Exp: 2018-02-15Common Stock (50,000 underlying)
  • Exercise/Conversion

    Common Stock

    2011-03-25$2.68/sh+50,000$134,000194,478 total
  • Sale

    Common Stock

    2011-03-25$3.90/sh50,000$195,000144,478 total
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2011-03-25$3.90/sh77,142$300,85422,858 total
    Exercise: $2.54From: 2007-03-11Exp: 2017-04-09Common Stock (77,142 underlying)
  • Sale

    Common Stock

    2011-03-25$3.90/sh77,142$300,854144,478 total
Footnotes (8)
  • [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 05/28/2010.
  • [F2]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 05/28/2010.
  • [F3]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 05/28/2010.
  • [F4]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 05/28/2010.
  • [F5]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 05/28/2010.
  • [F6]Indicates vesting commencement date; the stock option becomes exercisable as to the option's original share total over 48 months, at the rate of 20% six months from the vesting commencement date and the remaining 80% vesting in equal increments at the end of each quarterly period thereafter.
  • [F7]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 05/28/2010.
  • [F8]Indicates vesting commencement date; the stock option becomes exercisable as to the option's original share total over 48 months, at the rate of 20% six months from the vesting commencement date and the remaining 80% vesting in equal increments at the end of each quarterly period thereafter.

Issuer

DRUGSTORE COM INC

CIK 0001086467

Entity typeother

Related Parties

1
  • filerCIK 0001384516

Filing Metadata

Form type
4
Filed
Mar 28, 8:00 PM ET
Accepted
Mar 29, 5:32 PM ET
Size
14.4 KB